A carregar...
Red Blood Cell Product Utilization in Patients Undergoing Allogeneic Stem Cell Transplantation
BACKGROUND: The risk of transfusion reactions (TR) and the cost of blood has led to efforts to reduce blood use. We changed our practice to transfuse just 1 instead of 2 units of red blood cells (RBC) when hemoglobin ≤8g/dl due to patient blood management (PBM) recommendations. METHODS AND MATERIALS...
Na minha lista:
| Publicado no: | Transfusion |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7713712/ https://ncbi.nlm.nih.gov/pubmed/30957250 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/trf.15285 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|